References
Cook, G.C.; Mulligan, R. and Sherlock, S.: Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Quarterly Journal of Medicine (new series) 40: 159 (1971).
Cooksley, W.G.E. and Powell, L. W.: Drug metabolism and interaction with particular reference to the liver. Drugs 2: 177(1971).
Fung, W.P and Khoo, O.T.: Active chronic hepatitis and recurrent and persistent hepatitis in Singapore patients. Medical Journal of Australia 2: 84 (1969).
Fung, W.P.; Tan, K.K. and Tye, C.Y.: Chronic hepatitis — Clinicopathological differentiation between active chronic hepatitis and recurrent or persistent (viral) hepatitis. Singapore Med. Journal 13: 216 (1972).
Mistilis, S.P. and Blackburn, C.R.B.: 6-Mercaptopurine and azathioprine in the treatment of active chronic hepatitis. Australasian Annals of Medicine 16: 305 (1967).
Mistilis, S.P.; Blackburn, CR.B. and Fung, W.P.: The use of 6-mercaptopurine and imuran in the treatment of active chronic hepatitis. Tijdschrift voor gastroenterologie 10 b (suppl.): 478 (1967).
Mistilis, S.P; Skyring, A.P and Blackburn. C.R.B.: Natural history of active chronic hepatitis. Australasian Annals of Medicine 17: 214 (1968).
Mistilis, S.P. and Blackburn, C.R.B.: Active chronic hepatitis. American Journal of Medicine 48: 484 (1970).
Murray-Lyon, I.M.; Stern, R.B. and Williams, R.: Controlled trial of prednisolone and azathioprine in active chronic hepatitis. Lancet 1: 735 (1973).
Soloway, R.D.; Summerskill, W.H.J.; Baggenstoss, A.H.; Geall, M.G.; Gitnick, G.L.; Elveback, L.R. and Schoenfield, L.J.:‘Lupoid’ hepatitis, a nonentity in the spectrum of chronic active liver disease. Gastroenterology 63: 820 (1972).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fung, WP. Clinical Use of Corticosteroid and Immunosuppressive Drugs in Liver Disease. Drugs 8, 139–145 (1974). https://doi.org/10.2165/00003495-197408020-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197408020-00007